Harnessing the Power of Eph/ephrin Biosemiotics for Theranostic Applications
Comprehensive basic biological knowledge of the Eph/ephrin system in the physiologic setting is needed to facilitate an understanding of its role and the effects of pathological processes on its activity, thereby paving the way for development of prospective therapeutic targets. To this end, this re...
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-06-01
|
Series: | Pharmaceuticals |
Subjects: | |
Online Access: | https://www.mdpi.com/1424-8247/13/6/112 |
id |
doaj-a020badab1314fdaa47496674f2d2222 |
---|---|
record_format |
Article |
spelling |
doaj-a020badab1314fdaa47496674f2d22222020-11-25T03:51:56ZengMDPI AGPharmaceuticals1424-82472020-06-011311211210.3390/ph13060112Harnessing the Power of Eph/ephrin Biosemiotics for Theranostic ApplicationsRobert M. Hughes0Jitka A.I. Virag1Department of Chemistry, East Carolina University, Science and Technology Building, SZ564, East 5th St, Greenville, NC 27858, USADepartment of Physiology, Brody School of Medicine, East Carolina University, Warren Life Sciences Building, LSB239, 600 Moye Blvd, Greenville, NC 27834, USAComprehensive basic biological knowledge of the Eph/ephrin system in the physiologic setting is needed to facilitate an understanding of its role and the effects of pathological processes on its activity, thereby paving the way for development of prospective therapeutic targets. To this end, this review briefly addresses what is currently known and being investigated in order to highlight the gaps and possible avenues for further investigation to capitalize on their diverse potential.https://www.mdpi.com/1424-8247/13/6/112Eph/ephrinreceptor tyrosine kinasetherapeutic targetsmart drugnanoparticlesliposomes |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Robert M. Hughes Jitka A.I. Virag |
spellingShingle |
Robert M. Hughes Jitka A.I. Virag Harnessing the Power of Eph/ephrin Biosemiotics for Theranostic Applications Pharmaceuticals Eph/ephrin receptor tyrosine kinase therapeutic target smart drug nanoparticles liposomes |
author_facet |
Robert M. Hughes Jitka A.I. Virag |
author_sort |
Robert M. Hughes |
title |
Harnessing the Power of Eph/ephrin Biosemiotics for Theranostic Applications |
title_short |
Harnessing the Power of Eph/ephrin Biosemiotics for Theranostic Applications |
title_full |
Harnessing the Power of Eph/ephrin Biosemiotics for Theranostic Applications |
title_fullStr |
Harnessing the Power of Eph/ephrin Biosemiotics for Theranostic Applications |
title_full_unstemmed |
Harnessing the Power of Eph/ephrin Biosemiotics for Theranostic Applications |
title_sort |
harnessing the power of eph/ephrin biosemiotics for theranostic applications |
publisher |
MDPI AG |
series |
Pharmaceuticals |
issn |
1424-8247 |
publishDate |
2020-06-01 |
description |
Comprehensive basic biological knowledge of the Eph/ephrin system in the physiologic setting is needed to facilitate an understanding of its role and the effects of pathological processes on its activity, thereby paving the way for development of prospective therapeutic targets. To this end, this review briefly addresses what is currently known and being investigated in order to highlight the gaps and possible avenues for further investigation to capitalize on their diverse potential. |
topic |
Eph/ephrin receptor tyrosine kinase therapeutic target smart drug nanoparticles liposomes |
url |
https://www.mdpi.com/1424-8247/13/6/112 |
work_keys_str_mv |
AT robertmhughes harnessingthepowerofephephrinbiosemioticsfortheranosticapplications AT jitkaaivirag harnessingthepowerofephephrinbiosemioticsfortheranosticapplications |
_version_ |
1724485501326458880 |